Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037596709> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W3037596709 endingPage "126" @default.
- W3037596709 startingPage "117" @default.
- W3037596709 abstract "INTRODUCTION The efficacy of abatacept has been demonstrated mainly in case reports, case series, and observational studies with small sample size. With current evidence, it is premature to conclude that abatacept is an effective treatment for nephrotic syndrome. MATERIALS AND METHODS We searched MEDLINE, SCOPUS, and Cochrane Library until December 2019 for studies including patients with focal segmental glomerulosclerosis (FSGS) or minimal change disease (MCD) treated with abatacept. Proteinuria recovery and remission were outcomes of interest. Presence of urinary CD80 level of B7-1 staining on kidney biopsies was also reported. RESULTS A total of 11 studies (n = 32) were included in the systematic review. 60% of patients were male. The median age was 27.5 years (range 5.2 - 72 years). Approximately 90.6% had FSGS, while 9.4% had MCD. With median follow-up of 12 months (IQR 6.38), only 15 patients (46.9%) showed response in proteinuria reduction, and 12 patients (43.8%) achieved remission with abatacept. Serious adverse events were reported in 12.5%. Additionally, we observed that patients with positive B7-1 staining on kidney biopsies had higher odds of achieving remission with abatacept (likelihood ratio 18.25; p < 0.001). We found no significant correlation between elevated CD80 levels and remissions. CONCLUSION The efficacy of abatacept therapy for FSGS or MCD was only 43.8%. Serious adverse effects are common. However, our study suggested that abatacept should be considered only in patients with positive B7-1 staining on kidney biopsy because these patients tend to respond to treatment." @default.
- W3037596709 created "2020-07-02" @default.
- W3037596709 creator A5012461037 @default.
- W3037596709 creator A5038578876 @default.
- W3037596709 creator A5050210985 @default.
- W3037596709 date "2020-09-01" @default.
- W3037596709 modified "2023-10-12" @default.
- W3037596709 title "Efficacy of abatacept treatment for focal segmental glomerulosclerosis and minimal change disease: A systematic review of case reports, case series, and observational studies" @default.
- W3037596709 doi "https://doi.org/10.5414/cn110134" @default.
- W3037596709 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32589135" @default.
- W3037596709 hasPublicationYear "2020" @default.
- W3037596709 type Work @default.
- W3037596709 sameAs 3037596709 @default.
- W3037596709 citedByCount "10" @default.
- W3037596709 countsByYear W30375967092021 @default.
- W3037596709 countsByYear W30375967092022 @default.
- W3037596709 countsByYear W30375967092023 @default.
- W3037596709 crossrefType "journal-article" @default.
- W3037596709 hasAuthorship W3037596709A5012461037 @default.
- W3037596709 hasAuthorship W3037596709A5038578876 @default.
- W3037596709 hasAuthorship W3037596709A5050210985 @default.
- W3037596709 hasConcept C126322002 @default.
- W3037596709 hasConcept C141071460 @default.
- W3037596709 hasConcept C177713679 @default.
- W3037596709 hasConcept C23131810 @default.
- W3037596709 hasConcept C2777747828 @default.
- W3037596709 hasConcept C2778415529 @default.
- W3037596709 hasConcept C2779338263 @default.
- W3037596709 hasConcept C2779605438 @default.
- W3037596709 hasConcept C2780091579 @default.
- W3037596709 hasConcept C2780368995 @default.
- W3037596709 hasConcept C2780653079 @default.
- W3037596709 hasConcept C71924100 @default.
- W3037596709 hasConceptScore W3037596709C126322002 @default.
- W3037596709 hasConceptScore W3037596709C141071460 @default.
- W3037596709 hasConceptScore W3037596709C177713679 @default.
- W3037596709 hasConceptScore W3037596709C23131810 @default.
- W3037596709 hasConceptScore W3037596709C2777747828 @default.
- W3037596709 hasConceptScore W3037596709C2778415529 @default.
- W3037596709 hasConceptScore W3037596709C2779338263 @default.
- W3037596709 hasConceptScore W3037596709C2779605438 @default.
- W3037596709 hasConceptScore W3037596709C2780091579 @default.
- W3037596709 hasConceptScore W3037596709C2780368995 @default.
- W3037596709 hasConceptScore W3037596709C2780653079 @default.
- W3037596709 hasConceptScore W3037596709C71924100 @default.
- W3037596709 hasIssue "3" @default.
- W3037596709 hasLocation W30375967091 @default.
- W3037596709 hasOpenAccess W3037596709 @default.
- W3037596709 hasPrimaryLocation W30375967091 @default.
- W3037596709 hasRelatedWork W143909947 @default.
- W3037596709 hasRelatedWork W1607845510 @default.
- W3037596709 hasRelatedWork W1765855 @default.
- W3037596709 hasRelatedWork W2042732525 @default.
- W3037596709 hasRelatedWork W2274832634 @default.
- W3037596709 hasRelatedWork W2440118131 @default.
- W3037596709 hasRelatedWork W2776541736 @default.
- W3037596709 hasRelatedWork W2898320864 @default.
- W3037596709 hasRelatedWork W3122312189 @default.
- W3037596709 hasRelatedWork W4256015928 @default.
- W3037596709 hasVolume "94" @default.
- W3037596709 isParatext "false" @default.
- W3037596709 isRetracted "false" @default.
- W3037596709 magId "3037596709" @default.
- W3037596709 workType "article" @default.